Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen's talimogene laherparepvec reduced size of tumors in Phase 3 study
Amgen's talimogene laherparepvec reduced size of tumors in Phase 3 study
Amgen's talimogene laherparepvec reduced size of tumors in Phase 3 study
Submitted by
admin
on March 15, 2014 - 10:03am
Source:
Yahoo/The Fly on the Wall
News Tags:
Amgen
Talimogene Laherparepvec
melanoma
Headline:
Amgen's talimogene laherparepvec reduced size of tumors in Phase 3 study
Do Not Allow Advertisers to Use My Personal information
